Literature DB >> 29397262

Consequences of dysregulated complement regulators on red blood cells.

Astrid J F Thielen1, Sacha Zeerleder2, Diana Wouters3.   

Abstract

The complement system represents the first line of defense that is involved in the clearance of pathogens, dying cells and immune complexes via opsonization, induction of an inflammatory response and the formation of a lytic pore. Red blood cells (RBCs) are very important for the delivery of oxygen to tissues and are continuously in contact with complement proteins in the blood plasma. To prevent complement activation on RBCs, various complement regulatory proteins can be found in plasma and on the cell membrane. RBCs are special cells without a nucleus and having a slightly different make-up of complement regulators than nucleated cells, as membrane cofactor protein (MCP) is not expressed and complement receptor 1 (CR1) is highly expressed. Decreased expression and/or function of complement regulatory proteins may result in unwanted complement activation and accelerated removal of RBCs. This review describes complement regulation on RBCs and the consequences when this regulation is out of balance.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anemia; Complement activation; Hemolysis; Red blood cells; Regulation

Mesh:

Substances:

Year:  2018        PMID: 29397262     DOI: 10.1016/j.blre.2018.01.003

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  5 in total

Review 1.  Rosetting revisited: a critical look at the evidence for host erythrocyte receptors in Plasmodium falciparum rosetting.

Authors:  Fiona McQuaid; J Alexandra Rowe
Journal:  Parasitology       Date:  2019-09-16       Impact factor: 3.234

Review 2.  Coronavirus disease 2019 (COVID-19), human erythrocytes and the PKC-alpha/-beta inhibitor chelerythrine -possible therapeutic implication.

Authors:  Mehrdad Ghashghaeinia; Peter Dreischer; Thomas Wieder; Martin Köberle
Journal:  Cell Cycle       Date:  2020-12-11       Impact factor: 4.534

3.  Clinical Impact of the ABO Blood Type in Patients with Rheumatic Diseases: Is there a Link to the ABO and Rhesus?

Authors:  Gehan I Salem; Nada M Gamal; Esraa A Talaat; Dina H El-Hammady; Nevin Hammam; Tamer A Gheita
Journal:  Mediterr J Rheumatol       Date:  2021-09-30

4.  Human erythrocytes, nuclear factor kappaB (NFκB) and hydrogen sulfide (H2S) - from non-genomic to genomic research.

Authors:  Mehrdad Ghashghaeinia; Ulrich Mrowietz
Journal:  Cell Cycle       Date:  2021-09-24       Impact factor: 4.534

5.  Evolution of red blood cell membrane complement regulatory proteins and rheology in septic patients: An exploratory study.

Authors:  Julie Vanderelst; Alexandre Rousseau; Nicolas Selvais; Patrick Biston; Karim Zouaoui Boudjeltia; Michaël Piagnerelli
Journal:  Front Med (Lausanne)       Date:  2022-07-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.